These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3485641)

  • 1. Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET.
    Hawkins RA; Phelps ME; Huang SC
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):170-83. PubMed ID: 3485641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.
    Evans AC; Diksic M; Yamamoto YL; Kato A; Dagher A; Redies C; Hakim A
    J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
    Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
    Mizukawa N; Hino A; Imahori Y; Tenjin H; Yano I; Yoshino E; Hirakawa K; Yamashita M; Oki F; Nakahashi H
    No To Shinkei; 1989 Mar; 41(3):251-8. PubMed ID: 2787998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of kinetic rate constants for 2-[18F]fluoro-2-deoxy-D-glucose and partition coefficient of water in conscious macaques and alterations in aging or anesthesia examined on parametric images with an anatomic standardization technique.
    Noda A; Takamatsu H; Minoshima S; Tsukada H; Nishimura S
    J Cereb Blood Flow Metab; 2003 Dec; 23(12):1441-7. PubMed ID: 14663339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of biological and technical factors on the variability of global and regional brain metabolism of 2-[18F]fluoro-2-deoxy-D-glucose.
    Camargo EE; Szabo Z; Links JM; Sostre S; Dannals RF; Wagner HN
    J Cereb Blood Flow Metab; 1992 Mar; 12(2):281-90. PubMed ID: 1548300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kinetic evaluation of blood-brain barrier permeability in human brain tumors with [68Ga]EDTA and positron computed tomography.
    Hawkins RA; Phelps ME; Huang SC; Wapenski JA; Grimm PD; Parker RG; Juillard G; Greenberg P
    J Cereb Blood Flow Metab; 1984 Dec; 4(4):507-15. PubMed ID: 6438122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
    Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
    No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine.
    Wienhard K; Herholz K; Coenen HH; Rudolf J; Kling P; Stöcklin G; Heiss WD
    J Nucl Med; 1991 Jul; 32(7):1338-46. PubMed ID: 1906093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
    Brooks DJ; Beaney RP; Lammertsma AA; Herold S; Turton DR; Luthra SK; Frackowiak RS; Thomas DG; Marshall J; Jones T
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):230-9. PubMed ID: 3007547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
    Kuwabara H; Evans AC; Gjedde A
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of kinetic rate constants in [18F]fluorodeoxyglucose model using a least square fitting package SALS (statistical analysis with least squares).
    Uehara S; Kuwabara Y; Ichiya Y; Otsuka M; Ayabe Y; Miyake Y; Masuda K; Yoshimura A
    Radioisotopes; 1987 Dec; 36(12):653-6. PubMed ID: 3502293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hyperglycemia on FDG uptake in human brain and glioma.
    Ishizu K; Nishizawa S; Yonekura Y; Sadato N; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Miyatake S; Ishikawa M
    J Nucl Med; 1994 Jul; 35(7):1104-9. PubMed ID: 8014665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.
    Phelps ME; Huang SC; Hoffman EJ; Selin C; Sokoloff L; Kuhl DE
    Ann Neurol; 1979 Nov; 6(5):371-88. PubMed ID: 117743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computer simulation study on the input function sampling schedules in tracer kinetic modeling with positron emission tomography (PET).
    Feng D; Wang X; Yan H
    Comput Methods Programs Biomed; 1994 Nov; 45(3):175-86. PubMed ID: 7705075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculation of the FDG lumped constant by simultaneous measurements of global glucose and FDG metabolism in humans.
    Hasselbalch SG; Madsen PL; Knudsen GM; Holm S; Paulson OB
    J Cereb Blood Flow Metab; 1998 Feb; 18(2):154-60. PubMed ID: 9469157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of PET studies in brain tumors.
    Herholz K; Wienhard K; Heiss WD
    Cerebrovasc Brain Metab Rev; 1990; 2(3):240-65. PubMed ID: 2121212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
    Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.